Company / Assets per Share
Sonoma Pharmaceuticals, Inc. Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$17.55
FY2025
5-year range
$2.99 / $17.55
FY2021-FY2025
Trend
+487.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +487% YoY in FY2025, a notable deviation from the 8-year average annual change of +85%.
Based on SEC 10-K filings.
17.55 in FY2025 with a 5-year CAGR of +9.7%.
Improved from $5.23 to $17.55 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +24.9%
- 5-Year CAGR
- +9.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 487.3% year-over-year.
- Peak assets per share was recorded in FY2019.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $17.55 | +487.3% |
| FY2024 | $2.99 | -42.9% |
| FY2023 | $5.23 | -41.9% |
| FY2022 | $9.00 | +6.8% |
| FY2021 | $8.43 | -23.8% |
| FY2020 | $11.06 | -47.5% |
| FY2019 | $21.07 | +370.5% |
| FY2018 | $4.48 | -26.2% |
| FY2017 | $6.07 | +561.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026